RecruitingNot Applicable

Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

United States265 participantsStarted 2024-11-17

Plain-language summary

The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine among African American parents of vaccine-eligible daughters. The main question it aims to answer is: • Does culturally targeted messaging increase African American parents' intentions to vaccinate their daughter against HPV? Research will compare culturally targeted messaging to general, educational messaging and no messaging. Participants will: * View culturally targeted messages, education-only messages, or no messages about the HPV vaccine * Report their intentions to vaccinate their daughter against HPV * Report whether they have initiated HPV vaccination for their daughter six months later

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Identify as Black/African American or White/Caucasian * Have at least one daughter who is between 8-17 years of age, who is not currently pregnant, and who has not received any doses of the HPV vaccine Exclusion Criteria: * N/A

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

HPV Vaccine Attitudes

Timeframe: Immediately following and 6-months post-health messaging

HPV Vaccine Normative Beliefs

Timeframe: Immediately following and 6-months post-health messaging

HPV Vaccine Perceived Behavioral Control

Timeframe: Immediately following and 6-months post-health messaging

HPV Vaccine Intentions

Timeframe: Immediately following and 6-months post-health messaging

Vaccination Initiation

Timeframe: 6-months post-health messaging

Vaccination Discussion

Timeframe: 6-months post-health messaging

Trial details

NCT IDNCT07301905

SponsorMichigan State University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06

Contact for this trial

Olivia Aspiras, PhD

810-600-9181 aspiraso@msu.edu

View on ClinicalTrials.gov More HPV Vaccination trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

HPV Vaccine Attitudes

Timeframe: Immediately following and 6-months post-health messaging

HPV Vaccine Normative Beliefs

Timeframe: Immediately following and 6-months post-health messaging

HPV Vaccine Perceived Behavioral Control

Timeframe: Immediately following and 6-months post-health messaging

HPV Vaccine Intentions

Timeframe: Immediately following and 6-months post-health messaging

Vaccination Initiation

Timeframe: 6-months post-health messaging

Vaccination Discussion

Timeframe: 6-months post-health messaging